Literature DB >> 23887158

PHF1 rearrangements in ossifying fibromyxoid tumors of soft parts: A fluorescence in situ hybridization study of 41 cases with emphasis on the malignant variant.

Rondell P Graham1, Sharon W Weiss, William R Sukov, John R Goldblum, Steven D Billings, Snjezana Dotlic, Andrew L Folpe.   

Abstract

Ossifying fibromyxoid tumor of soft parts (OFMT) is a rare soft tissue neoplasm of uncertain differentiation. Very recently recurrent rearrangements of the PHF1 gene have been reported in OFMT, including typical, atypical, and malignant variants. We sought to validate and extend these findings in a larger series of well-characterized OFMT, in particular malignant variants. Slides and blocks from 41 OFMT were retrieved, rereviewed, and classified as typical, atypical, and malignant using previously published criteria. Interphase fluorescence in situ hybridization (FISH) was performed on paraffin-embedded sections of each case using a break-apart probe strategy, with direct-labeled FISH probes designed from bacterial artificial chromosomes. The 41 tumors occurred in 23 men and 18 women with a mean age of 55 years and involved the head and neck, trunk, and upper and lower limbs. The tumors were classified as typical (n=14), atypical (n=6) and malignant (n=21). PHF1 rearrangements were detected in 20 of 41 cases (49%) including 43% typical, 50% atypical, and 52% malignant cases. The results of our study confirm previous findings, with PHF1 rearrangements present in nearly 50% of OFMT, including roughly similar percentages of typical, atypical, and malignant tumors. These results support our previous hypothesis that OFMT might represent a translocation-associated tumor, underscore the likely importance of PHF1 rearrangements in the pathogenesis of these lesions, confirm the relationship between typical and malignant OFMT, and suggest a role for PHF1 FISH in the diagnosis of morphologically challenging cases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887158     DOI: 10.1097/PAS.0b013e31829644b4

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

Review 1.  What is new about the molecular genetics in matrix-producing soft tissue tumors? -The contributions to pathogenetic understanding and diagnostic classification.

Authors:  Yu-Chien Kao; Jen-Chieh Lee; Hsuan-Ying Huang
Journal:  Virchows Arch       Date:  2019-11-07       Impact factor: 4.064

2.  Novel recurrent PHF1-TFE3 fusions in ossifying fibromyxoid tumors.

Authors:  Albert J H Suurmeijer; Wangzhao Song; Yun-Shao Sung; Lei Zhang; David Swanson; Christopher D M Fletcher; Brendan C Dickson; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2019-04-17       Impact factor: 5.006

3.  Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.

Authors:  Yu-Chien Kao; Yun-Shao Sung; Lei Zhang; Chun-Liang Chen; Shih-Chiang Huang; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2016-08-26       Impact factor: 5.006

Review 4.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

5.  Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma.

Authors:  Cristina R Antonescu; Yun-Shao Sung; Chun-Liang Chen; Lei Zhang; Hsiao-Wei Chen; Samuel Singer; Narasimhan P Agaram; Andrea Sboner; Christopher D Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2013-11-28       Impact factor: 5.006

Review 6.  Epigenetic Alterations in Bone and Soft Tissue Tumors.

Authors:  John Wojcik; Kumarasen Cooper
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

Review 7.  Soft Tissue Special Issue: Myoepithelial Neoplasms of Soft Tissue: An Updated Review with Emphasis on Diagnostic Considerations in the Head and Neck.

Authors:  Vickie Y Jo
Journal:  Head Neck Pathol       Date:  2020-01-16

8.  Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma.

Authors:  Francesca Micci; Marta Brunetti; Paola Dal Cin; Marisa R Nucci; Ludmila Gorunova; Sverre Heim; Ioannis Panagopoulos
Journal:  Genes Chromosomes Cancer       Date:  2017-09-06       Impact factor: 5.006

9.  Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor.

Authors:  Salvatore Provenzano; Alessandra Raimondi; Rossella M Bertulli; Vittoria Colia; Salvatore L Renne; Paola Collini; Gianpaolo Dagrada; Dario Callegaro; Marco Fiore; Francesca G Greco; Paolo G Casali
Journal:  Clin Sarcoma Res       Date:  2017-12-28

10.  Primary malignant ossifying fibromyxoid tumour of the bone. A clinicopathologic and molecular report of two cases.

Authors:  Marta Sbaraglia; Elena Bellan; Marco Gambarotti; Alberto Righi; Lucia Zanatta; Luisa Toffolatti; Angelo P Dei Tos
Journal:  Pathologica       Date:  2020-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.